Pacira BioSciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCRX and other ETFs, options, and stocks.

About PCRX

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. 

CEO
Frank D. Lee
CEOFrank D. Lee
Employees
829
Employees829
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2006
Founded2006
Employees
829
Employees829

PCRX Key Statistics

Market cap
916.43M
Market cap916.43M
Price-Earnings ratio
68.30
Price-Earnings ratio68.30
Dividend yield
Dividend yield
Average volume
916.39K
Average volume916.39K
High today
$23.37
High today$23.37
Low today
$22.79
Low today$22.79
Open price
$23.21
Open price$23.21
Volume
636.85K
Volume636.85K
52 Week high
$27.66
52 Week high$27.66
52 Week low
$18.80
52 Week low$18.80

Stock Snapshot

As of today, Pacira BioSciences(PCRX) shares are valued at $23.00. The company's market cap stands at 916.43M, with a P/E ratio of 68.30.

During the trading session on 2026-08-15, Pacira BioSciences(PCRX) shares reached a daily high of $23.37 and a low of $22.79. At a current price of $23.00, the stock is +0.9% higher than the low and still -1.6% under the high.

Trading volume for Pacira BioSciences(PCRX) stock has reached 636.85K, versus its average volume of 916.39K.

The stock's 52-week range extends from a low of $18.80 to a high of $27.66.

The stock's 52-week range extends from a low of $18.80 to a high of $27.66.

PCRX News

Simply Wall St 5d
Pacira BioSciences Is Down 7.1% After Advancing PCRX-201 Gene Therapy With Positive Phase 1 Data

Pacira BioSciences recently reported that its investigational gene therapy PCRX-201 for knee osteoarthritis showed positive two-year Phase 1 results, with a sin...

Pacira BioSciences Is Down 7.1% After Advancing PCRX-201 Gene Therapy With Positive Phase 1 Data

Analyst ratings

50%

of 6 ratings
Buy
50%
Hold
33.3%
Sell
16.7%

People also own

Based on the portfolios of people who own PCRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.